Skip to main content
Elsevier
View Cart

Molecular Targets and Therapeutic Design

  • 1st Edition, Volume 153 - September 1, 2026
  • Latest edition
  • Editor: Rossen Donev
  • Language: English

Molecular Targets and Therapeutic Design, Volume 152 provides a comprehensive overview of the current landscape and future directions in the identification and exploitat… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Molecular Targets and Therapeutic Design, Volume 152 provides a comprehensive overview of the current landscape and future directions in the identification and exploitation of molecular targets for the development of new therapeutics. This volume brings together leading experts to discuss the fundamental principles of target discovery, validation, and the strategies used to design molecules that modulate biological pathways in disease. Topics covered in this new release include Recent Strategies and Approaches for the Development of Molecularly Targeted Nanomedicine, Transcriptomic Profiling for Therapeutic Target Discovery in Neuropsychiatric Conditions, Transcriptomic Insights into Hormone-Driven Malignancies: Toward Targeted Therapeutic Strategies, and much more.

Additional chapters cover Targeting Kinases in Neurodegenerative Diseases and Cancer: Structural Insights and Therapeutic Strategies, Small molecular therapeutic targets for neurodegenerative diseases, Signaling cascades of Tau protein, Understanding molecular role of lipids for Alzheimer's disease, Clinical Challenges and Therapeutic Strategies in Chordoma, Molecular Characterization and Experimental Models of Chordoma, Disordered Proteins as Fuzzy Viral Drug Targets, amongst other timely topics.

Key features

  • Explores a wide range of molecular targets involved in human diseases, including enzymes, receptors, ion channels, and nucleic acids
  • Discusses innovative approaches for therapeutic design, including small molecules, biologics, and gene therapies
  • Bridges basic research with clinical applications, highlighting the pathway from molecular discovery to drug development

Readership

Academic Researchers, University Faculty and Students, Pharmaceutical and Biotechnology Professionals

Table of contents

1. Recent Strategies and Approaches for the Development of Molecularly Targeted Nanomedicine
Balak Das Kurmi, Preeti Patel and Aman Kumar

2. Transcriptomic Profiling for Therapeutic Target Discovery in Neuropsychiatric Conditions
Karthick Vasudevan

3. Transcriptomic Insights into Hormone-Driven Malignancies: Toward Targeted Therapeutic Strategies
Karthick Vasudevan

4. Targeting Kinases in Neurodegenerative Diseases and Cancer: Structural Insights and Therapeutic Strategies
Anas Shamsi

5. Small molecular therapeutic targets for neurodegenerative diseases
Subashchandrabose Chinnathambi, Nagaraj Rangappa, Riddhi Bharatkumar Upadhyay, Sivasamy Ramasamy, Murugan Sevanan and Nathish Lakshman

6. Signaling cascades of Tau protein
Subashchandrabose Chinnathambi

7. Understanding molecular role of lipids for Alzheimer's disease
Subashchandrabose Chinnathambi

8. Neuroinflammation- molecular target based therapeutic approach
Deepraj Paul

9. Clinical Challenges and Therapeutic Strategies in Chordoma
Margot Martinez-Moreno and Beatrice Campilan

10. Molecular Characterization and Experimental Models of Chordoma
Margot Martinez-Moreno and Beatrice Campilan

11. Disordered Proteins as Fuzzy Viral Drug Targets
Selvaraj Chandrabose Sr.

12. Marine-Derived Bioactives as Precision Modulators of Molecular Targets: Emerging Paradigms in Therapeutic Design
Selvaraj Chandrabose Sr.

13. Precision Therapeutics for Wound Healing: Molecular Targets, Signaling Networks, and Advanced Drug Design Strategies
Ashokkumar Sibiya

14. Exploring the efficacy of β-lactam and β-lactamase inhibitors/β-lactam enhancer against carbapenem-resistant Acinetobacter baumannii: An in vitro and in silico analysis
George Priya Doss C

15. Screening of prospective biofilm-inhibitory drug candidates aimed at the biofilm-associated protein (BAP) in Staphylococcus aureus: An in-silico investigation
George Priya Doss C, Mangesh R, Sree Haryini and Mohanraj Gopikrishnan

Product details

  • Edition: 1
  • Latest edition
  • Volume: 153
  • Published: September 1, 2026
  • Language: English

About the editor

RD

Rossen Donev

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
Affiliations and expertise
Head of Research, MicroPharm Limited, UK